Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Drug Resistance

Free Subscription 16.03.2026 14 Antimicrob Agents Chemother 1 Antivir Ther 1 BMJ 4 Int J Antimicrob Agents 4 J Antimicrob Chemother 1 J Clin Microbiol 1 J Infect Chemother 1 N Engl J Med 1 Nat Med 7 PLoS One 1 Sex Transm Infect

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. YIN T, Qu B, Zhang Q, Xu S, et al
   Pharmacokinetics, safety, and tolerability of HRS-8427, a novel anti-carbapenem-resistant cephalosporin, in healthy subjects.
   Antimicrob Agents Chemother. 2026 Mar 3:e0069425. doi: 10.1128/aac.00694.
   PubMed         Abstract available
   
   
2. PONTIKIS K, Karaiskos I, Sakagianni A, Mouloudi E, et al
   Comparative effectiveness of two antimicrobial regimens for the treatment of pan-drug-resistant Acinetobacter baumannii infections: results from the DESPAIR study.
   Antimicrob Agents Chemother. 2026;70:e0115425.
   PubMed         Abstract available
   
   
3. YANG X, Ning W, Yuan Y, Hou X, et al
   Novel metabolic adaptation driven by glycoside hydrolase family 25 protein contributes to increasing trimethoprim-sulfamethoxazole resistance in clinical human Brucella melitensis isolates in China.
   Antimicrob Agents Chemother. 2026;70:e0128425.
   PubMed         Abstract available
   
   
4. ZHOU W, Chen D, Dong X, Yang T, et al
   Emergence and genomic adaptation of the globally disseminated ST2250 lineage within the Staphylococcus aureus complex.
   Antimicrob Agents Chemother. 2026 Jan 26:e0162825. doi: 10.1128/aac.01628.
   PubMed         Abstract available
   
   
5. SHARMA P, Dean D, Read TD
   Putative azithromycin resistance mutations in Chlamydia trachomatis are globally distributed but arose before azithromycin was discovered.
   Antimicrob Agents Chemother. 2026 Jan 26:e0170825. doi: 10.1128/aac.01708.
   PubMed         Abstract available
   
   
6. GONZALEZ-DIAZ A, Pinto M, Cadenas-Jimenez I, Duarte S, et al
   First identification and molecular characterization of CTX-M-15 extended-spectrum beta-lactamase and OXA-9 beta-lactamase in Haemophilus influenzae in the Iberian Peninsula.
   Antimicrob Agents Chemother. 2026;70:e0164925.
   PubMed         Abstract available
   
   
7. LEPAK A, Bhavnani SM, Castanheira M, Rubino CM, et al
   Evaluation of an in vivo pulmonary aspergillosis model for triazole susceptibility breakpoint development.
   Antimicrob Agents Chemother. 2026 Jan 30:e0164325. doi: 10.1128/aac.01643.
   PubMed         Abstract available
   
   
8. DING R, Ma K, Zhang K, Liu J, et al
   Broxyquinoline enhances antibacterial activity of colistin and attenuates LPS-induced inflammation.
   Antimicrob Agents Chemother. 2026;70:e0139825.
   PubMed         Abstract available
   
   
9. WANG J, Zhu J, Wu W, Luo R, et al
   Clinical outcomes and safety of eravacycline in hematology: a multicenter, real-world study.
   Antimicrob Agents Chemother. 2026;70:e0128725.
   PubMed         Abstract available
   
   
10. ROYER M, Cabanel N, Gutierrez A, Royer G, et al
    The mecillinam resistome in Klebsiella pneumoniae: how resistance to a one-target beta-lactam triggers a diversity of responses.
    Antimicrob Agents Chemother. 2026;70:e0120725.
    PubMed         Abstract available
    
    
11. SONG Y, Buil JB, Zoll J, Tehupeiory-Kooreman M, et al
    Characteristics of individual cyp51A SNPs and combinations thereof impacting the azole phenotype in TR(34)-mediated resistance genotypes of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2026 Feb 3:e0152825. doi: 10.1128/aac.01528.
    PubMed         Abstract available
    
    
12. BAI Y-M, Gao X-J, Yue C, Cai Z-P, et al
    Salmonella Stanley ST29 carrying IncHI2/ST3-bla(NDM-5) plasmid emerged in a 4-month-old infant with diarrhea.
    Antimicrob Agents Chemother. 2026;70:e0147125.
    PubMed         Abstract available
    
    
13. LEHMAN D, Hetzler AE, Friedrich T, Strouse MM, et al
    Variable chlorhexidine MICs across Klebsiella species from a single facility.
    Antimicrob Agents Chemother. 2026;70:e0143625.
    PubMed         Abstract available
    
    
14. JOUSSET AB, Girlich D, Oueslati S, Birer A, et al
    In vivo selection of CMY-219 conferring resistance to ceftazidime-avibactam in an OXA-484-producing E. coli ST410.
    Antimicrob Agents Chemother. 2026;70:e0133525.
    PubMed         Abstract available
    
    

    
    Antivir Ther

15. BASSEL M, Romanus D, Bo T, Sundberg AK, et al
    Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation.
    Antivir Ther. 2023;28:13596535231195431.
    PubMed         Abstract available
    
    

    
    BMJ

16. MAHASE E
    Antimicrobial resistance: Pharma pipeline projects drop by over a third.
    BMJ. 2026;392:s479.
    PubMed        
    
    

    
    Int J Antimicrob Agents

17. PAN Y, Chen L, Zhang L, Li G, et al
    One health genomic insights into the host-specific evolution and cross-host transmission of Staphylococcus aureus in animal farm environments, food of animal origin, and humans.
    Int J Antimicrob Agents. 2023;62:106932.
    PubMed         Abstract available
    
    
18. GATO E, Guijarro-Sanchez P, Alonso-Garcia I, Pedraza-Merino R, et al
    In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification.
    Int J Antimicrob Agents. 2023;62:106935.
    PubMed         Abstract available
    
    
19. LEE YJ, Chang YC, Lee IH, Ho KH, et al
    Persistence and dynamic structures of diverse cephalosporinase genes in nontyphoidal Salmonella in cross-sectional surveillance in Taiwan.
    Int J Antimicrob Agents. 2023;62:106944.
    PubMed         Abstract available
    
    
20. SINGH R, Lin YW, Zhao J, Li J, et al
    Artificial intelligence and machine learning in antimicrobial discovery, resistance prediction, and precision therapy.
    Int J Antimicrob Agents. 2026;67:107715.
    PubMed         Abstract available
    
    

    
    J Antimicrob Chemother

21. PAUW HS, Schwarz R, Beij A, Sieswerda E, et al
    Antimicrobial therapy for infected necrotizing pancreatitis: microbiology, antimicrobial resistance and pharmacokinetics.
    J Antimicrob Chemother. 2026;81:dkag092.
    PubMed         Abstract available
    
    
22. SCHONENBERGER CM, Haenggi K, Ringera IK, Luoga E, et al
    HIV drug resistance amongst children and adolescents with viraemia in Lesotho and Tanzania: a nested analysis in the GIVE MOVE trial.
    J Antimicrob Chemother. 2026;81:dkag070.
    PubMed         Abstract available
    
    
23. KOIZUMI J, Otake R, Seyama S, Hayashi N, et al
    Functional analysis of a novel macrolide-lincosamide resistance gene erm(57) in Cutibacterium avidum.
    J Antimicrob Chemother. 2026;81:dkag029.
    PubMed         Abstract available
    
    
24. GRAZIANI L, Giani T, Farese A, Di Lauria N, et al
    Vancomycin resistance predicts increased mortality in patients with Enterococcus faecium bloodstream infections: a six-year experience at a large tertiary care Italian hospital.
    J Antimicrob Chemother. 2026;81:dkag069.
    PubMed         Abstract available
    
    

    
    J Clin Microbiol

25. ZAYDMAN MA, Glaser L, Herman DS, Kressloff M, et al
    Leveraging patient data to detect systematic shifts in daptomycin susceptibility testing associated with reduced prescribing.
    J Clin Microbiol. 2026;64:e0151025.
    PubMed         Abstract available
    
    

    
    J Infect Chemother

26. KOSAI K, Yamagishi Y, Mikamo H, Ishii Y, et al
    Epidemiological analysis and antimicrobial susceptibility profile of Gram-negative bacilli that cause bacteremia in Japan.
    J Infect Chemother. 2023;29:1091-1096.
    PubMed         Abstract available
    
    

    
    N Engl J Med

27. PUOPOLO KM
    Group B Streptococcal Disease.
    N Engl J Med. 2026;394:896-905.
    PubMed         Abstract available
    
    

    
    Nat Med

28. CHEN W, Zeng Y, Zheng J, Wang J, et al
    Evaluation of antimicrobial resistance governance across 193 countries to inform the 2026 Global Action Plan update.
    Nat Med. 2026 Mar 3. doi: 10.1038/s41591-026-04257.
    PubMed         Abstract available
    
    

    
    PLoS One

29. UDDIN MS, Chamonara K, Masum MHU, Siddiqua A, et al
    Genomic and phylogenomic exploration of Vibrio cholerae strain SU129B isolated from Penaeus vannamei: Resistance, virulence, and evolutionary dynamics in bangladeshi aquaculture.
    PLoS One. 2026;21:e0344787.
    PubMed         Abstract available
    
    
30. FLUIT AC, Bayjanov JR, Aguilar MD, Canton R, et al
    Qualitative analysis of genomic mutations and antibiotic susceptibility testing of Pseudomonas aeruginosa isolates from chronic lung infections.
    PLoS One. 2026;21:e0341613.
    PubMed         Abstract available
    
    
31. RODRIGUES RL, Rosa JAD, Cunha DDD, Nunes TL, et al
    Salmonella enterica persister cells exhibit distinct susceptibility profiles following exposure to human serum and macrophages.
    PLoS One. 2026;21:e0343532.
    PubMed         Abstract available
    
    
32. KOWAL C, Liu Y, Denis C, Arcangioli B, et al
    Hypomorphic mutations in ura6 confer 5-FOA resistance in fission yeast.
    PLoS One. 2026;21:e0344121.
    PubMed         Abstract available
    
    
33. ALEM K, Gizachew M, Dagnew M, Ferede W, et al
    Multidrug resistance patterns and carbapenemase production among Gram-negative bacteria causing healthcare-associated infections in hospitalized patients at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
    PLoS One. 2026;21:e0344280.
    PubMed         Abstract available
    
    
34. HARUTA A, Yoshikawa M, Takeuchi M, Kawada-Matsuo M, et al
    Oral and rectal colonization of Gram-negative antimicrobial-resistant bacteria and Methicillin-resistant Staphylococcus aureus in one long-term care facility and changes in professional oral hygiene care: Cross-sectional and interventional study.
    PLoS One. 2026;21:e0343092.
    PubMed         Abstract available
    
    
35. ZHAO S, Ye L, Song S, Sun J, et al
    KPC-33 and ompK37 mutations: Unraveling the mechanism of ceftazidime/avibactam resistance in ST11 carbapenem-resistant Klebsiella pneumoniae.
    PLoS One. 2026;21:e0342729.
    PubMed         Abstract available
    
    

    
    Sex Transm Infect

36. MCHUGH MP, Goldstein E, Cairns F, Calder C, et al
    Laboratory evaluation of the Allplex NG & DR assay for detection of Neisseria gonorrhoeae and associated azithromycin and ciprofloxacin resistance markers.
    Sex Transm Infect. 2026 Mar 5:sextrans-2025-056494.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum